Varicella Vaccine Live IP

Get a Price/Quote

MOQ : 50 Packs

Varicella Vaccine Live IP Specification

Packaging Type
Vial with accompanying sterile diluent ampoule

Dosage Form
Injection

Indication
Prevention of chickenpox (varicella)

Pacakaging (Quantity Per Box)
Single dose or multi-dose presentation (as indicated)

Life Span
24 months from date of manufacture

Salt Composition
Live attenuated varicella-zoster virus

Origin of Medicine
India

Drug Type
Biological vaccine

Ingredients
Live attenuated varicella-zoster virus (Oka strain)

Physical Form
Lyophilized powder with sterile diluent

Function
Active immunization against varicella (chickenpox)

Recommended For
Children, adolescents, and adults without immunity to varicella

Dosage
0.5 mL by subcutaneous injection

Dosage Guidelines
As directed by physician or according to immunization schedule

Suitable For
Suitable for individuals 12 months of age and older

Quantity
1 dose per vial

Storage Instructions
Store at 2C to 8C. Do not freeze.

Administration Route
Subcutaneous injection, preferably in the upper arm

Appearance After Reconstitution
Clear to slightly opaque liquid

Shelf Life (Unopened)
24 months at recommended storage

Time to Use After Reconstitution
Use immediately or within 30 minutes after reconstitution

Clinical Efficacy
Demonstrated protective efficacy against varicella in clinical trials

Contraindications
Contraindicated in immunocompromised individuals, pregnancy, and those with severe allergic reactions to any component

Safety Warning
Consult physician before use; not recommended during acute illness or fever

Reconstitution
Reconstitute only with the supplied sterile diluent before use

Varicella Vaccine Live IP Trade Information

Minimum Order Quantity
50 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About Varicella Vaccine Live IP

Varicella Vaccine Live IP offers dominant protection against chickenpox, harnessing a noble formulation with live attenuated varicella-zoster virus (Oka strain). Ready in a lyophilized powder form and supplied with a sterile diluent, it's administered via subcutaneous injection-preferably in the upper arm. Utilise the offer to pick yours, ensuring a lofty shield for children, adolescents, and adults above 12 months. Esteemed clinical trials have underscored its efficacy. Store at 2C to 8C. Provide unmatched safety for your community-consult your physician before use.

Type of Usage and Commercial Applications

Varicella Vaccine Live IP is intended for active immunization against varicella, suitable for use in hospitals, clinics, and preventive care programs. Commercially, it is an essential asset for immunization drives, public health initiatives, and private vaccination centers. The product features simplified administration, rapid reconstitution, and is adaptable for both single and multi-dose use, allowing suppliers and traders a streamlined vaccination process and maximized public health coverage across India.

Sample Policy, Certification, and Packing Details

Varicella Vaccine Live IP handover and sample policy are governed strictly by regulatory standards. Certified by national health authorities, it assures potent quality from manufacture to sale price negotiation. Each vial and its sterile diluent are securely packed for swift packing & dispatch-maintaining a cold chain from warehouse to point of care. Comprehensive documentation and certification are provided with every purchase, ensuring traceability and compliance with Indian and international vaccine regulations.

FAQ's of Varicella Vaccine Live IP:

Q: How should Varicella Vaccine Live IP be administered for best results?

A: It is administered subcutaneously, preferably in the upper arm, at a dose of 0.5 mL per patient as directed by a physician or per the recommended immunization schedule.

Q: What conditions contraindicate the usage of this vaccine?

A: It is contraindicated in immunocompromised individuals, pregnant women, and those with severe allergic reactions to any component of the vaccine.

Q: When should the reconstituted vaccine be used after mixing with the sterile diluent?

A: The reconstituted vaccine should be used immediately or within 30 minutes after reconstitution to ensure optimal efficacy and safety.

Q: Where should unopened vials of Varicella Vaccine Live IP be stored?

A: Store unopened vials at a temperature between 2C and 8C. The vaccine should never be frozen.

Q: What are the core benefits of using this varicella vaccine?

A: Clinical trials have demonstrated strong protective efficacy, making it a reliable preventive measure against chickenpox for individuals aged 12 months and older.

Q: How does the packaging support efficient commercial usage and safety?

A: Each dose comes in a secured vial with a sterile diluent ampoule, suitable for both single and multi-dose presentations, and is backed by strict cold chain logistics and certified safety documentation.

Tell us about your requirement